National Average Drug Acquisition Cost Weekly Data for 2025

NADAC (National Average Drug Acquisition Cost) weekly reference data for the 2025 calendar year, published by the U.S. Department of Health & Human Services. The dataset provides standardized cost benchmarks for pharmaceutical products.

Use Cases

• Analyze weekly NADAC price trends for specific drug products to monitor pharmaceutical cost inflation.
• Compare acquisition cost benchmarks across different drug categories or therapeutic classes.
• Integrate NADAC data with pharmacy claims to assess reimbursement rates against national averages.

Strengths

• Data is published by the authoritative U.S. Department of Health & Human Services.
• Provides weekly granularity for tracking price changes throughout the 2025 calendar year.
• Released under a public domain (us-pd) license, enabling broad use.

Limitations

• The dataset's specific size, row count, and column structure are unknown, limiting pre-analysis assessment.
• Data is limited to the 2025 calendar year and does not provide historical context without combining other releases.
• Lacks sample data or a defined schema, which may increase initial exploration time.

Provenance

Source

U.S. Department of Health & Human Services

Time Range

Calendar year 2025

Freshness

Data was last updated on January 9, 2026, indicating recent maintenance.

Geography

United States